{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1093/nar/gkx400",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.tools/mtctscan",
      "@type": "sc:SoftwareApplication",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0199"
        },
        {
          "@id": "edam:topic_3577"
        },
        {
          "@id": "edam:topic_0208"
        },
        {
          "@id": "edam:topic_3336"
        },
        {
          "@id": "edam:topic_2640"
        }
      ],
      "sc:citation": [
        "pubmed:28482068",
        {
          "@id": "https://doi.org/10.1093/nar/gkx400"
        },
        "pmcid:PMC5793836"
      ],
      "sc:description": "Mutation To Cancer Therapy Scan. Systematically analyze mutations affecting cancer drug sensitivity based on individual genomic profiles. It was developed by leveraging the latest knowledge on mutation-cancer drug sensitivity associations and the results from large-scale chemical screening using human cancer cell lines.",
      "sc:featureList": {
        "@id": "edam:operation_0224"
      },
      "sc:name": "mTCTScan",
      "sc:url": "http://jjwanglab.org/mTCTScan"
    }
  ]
}